This trial is testing a new combo treatment for CLL/SLL to see how effective it is at getting rid of disease.
1 Primary · 0 Secondary · Reporting Duration: 1 year
Experimental Treatment
127 Total Participants · 1 Treatment Group
Primary Treatment: Venetoclax · No Placebo Group · Phase 2
Age 18+ · All Participants · 10 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: